Condition
Polymyalgia Rheumatica (PMR) clinical trials and research
As of November 12, 2026, Find a Trial lists 8 Polymyalgia Rheumatica (PMR) clinical trials that are recruiting, at sites in 5 countries (most in France (2), Germany (2), Denmark (2)). By phase: Phase 3 (1), Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 8Clinical trials
- 5Countries
Newest Polymyalgia Rheumatica (PMR) clinical trials
All recruiting trials (8)
-
Personalized Movement Training to Help People with PMR Move Better
We’re testing whether a personalized Movement Pattern Training program can help people with polymyalgia rheumatica move more easily and reduce pain.
-
Baricitinib Added to Corticosteroids in PMR (Polymyalgia Rheumatica) May Improve Control
This study tests whether baricitinib plus low-dose steroids works better than steroids alone for people 50 and older with PMR.
-
Personalized lab test to predict the best treatment for rheumatic diseases
This project tests a lab-based cell assay to see if it can predict which DMARD will work best for adults with autoimmune rheumatic diseases such as RA, PsA, axSpA, and GCA.
-
Using PET and MRI scans to improve diagnosis and treatment of polymyalgia rheumatica
This project will try combined PET/CT and PET/MRI scans to see if they improve diagnosis and treatment choices for people over 50 with suspected polymyalgia rheumatica.
-
Investigating the Role of Y Chromosome Mutations in Autoimmune Diseases
This study is trying to see how changes in the Y chromosome might affect the immune system and contribute to autoimmune diseases like Giant Cell Arteritis and Polymyalgia Rheumatica.
-
Evaluating Thrombomodulin for Ruling Out Giant Cell Arteritis in Patients with Polymyalgia Rheumatica
This study is testing if a blood marker called thrombomodulin can help doctors tell if older patients with polymyalgia rheumatica also have giant cell arteritis.
-
Exploring factors that predict treatment response in patients with polymyalgia rheumatica and giant cell arteritis
This study is trying to find out what factors help predict how well new patients with polymyalgia rheumatica and giant cell arteritis will respond to steroid treatment.
-
Hydrocortisone vs. placebo for adrenal insufficiency symptoms after stopping glucocorticoids
This study is testing if hydrocortisone can help people over 50 feel better after stopping glucocorticoids and dealing with adrenal insufficiency symptoms.
Related topics
Quick answers
How many Polymyalgia Rheumatica (PMR) clinical trials are recruiting right now?
8, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 5 countries. The most sites are in France (2 trials), Germany (2 trials), Denmark (2 trials), Switzerland (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 1, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.